Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
WuXi XDC CaymanFRA:L74 -4.46%55 EV-to-FCF is 143.60 as of Sep. 01, 2026. GuruFocus rates FRA:L74 with a GF Score™ of 55/100. The stock has 3 warning signs investors should review. Among 104 Medical Diagnostics & Research companies, WuXi XDC Cayman ranks worse than 92.31% on this metric.
EV-to-FCF is calculated as enterprise value divided by its free cash flow. As of today, WuXi XDC Cayman's Enterprise Value is €9,119.2 Mil.
WuXi XDC Cayman's Free Cash Flow for the trailing twelve months (TTM) ended in Dec. 2025 was €63.5 Mil. Therefore, WuXi XDC Cayman's EV-to-FCF for today is 143.60.
The historical rank and industry rank for WuXi XDC Cayman's EV-to-FCF or its related term are showing as below:
FRA:L74'
s EV-to-FCF Range Over the Past 10 Years
Min: -133.13 Med: -57.63 Max: 685.81
Current: 143.09
During the past 6 years, the highest EV-to-FCF of WuXi XDC Cayman was 685.81. The lowest was -133.13. And the median was -57.63.
FRA:L74's EV-to-FCF is ranked worse than 92.31% of 104
companies
in the Medical Diagnostics & Research industry
Industry Median: 26.87
vs FRA:L74: 143.09
EV-to-FCF is a valuation multiple that allows analysts and investors to compare stocks, preferably in the same sector or industry. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio (TTM) to determine the fair market value of a company.
EV-to-FCF is a valuation multiple that allows analysts and investors to compare stocks, preferably in the same sector or industry. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio (TTM) to determine the fair market value of a company.
WuXi XDC Cayman's PE Ratio (TTM) for today is calculated as:
WuXi XDC Cayman's share price for today is €7.50.
For company reported semi-annually, GuruFocus uses latest annual data as the TTM data. WuXi XDC Cayman's Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Dec. 2025 was €0.144.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Enterprise Value is used because it is a more complete measure in reflecting how much an investor pays when buying a company. Free Cash Flow is an important financial metric because it represents the actual amount of cash at a company's disposal. Companies with a low EV-to-FCF ratio, combined with a strong balance sheet are generally considered as undervalued.
WuXi XDC Cayman EV-to-FCF Related Terms
WuXi XDC Cayman EV-to-FCF Historical Data
* Premium members only.
The historical data trend for WuXi XDC Cayman's EV-to-FCF can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
For the Diagnostics & Research subindustry, WuXi XDC Cayman's EV-to-FCF, along with its competitors' market caps and EV-to-FCF data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
WuXi XDC Cayman EV-to-FCF vs Medical Diagnostics & Research Industry
For the Medical Diagnostics & Research industry and Healthcare sector, WuXi XDC Cayman's EV-to-FCF distribution charts can be found below:
* The bar in red indicates where WuXi XDC Cayman's EV-to-FCF falls into.
WuXi XDC Cayman's current Enterprise Value is €9,119.2 Mil.
For company reported semi-annually, GuruFocus uses latest annual data as the TTM data. WuXi XDC Cayman's Free Cash Flow for the trailing twelve months (TTM) ended in Dec. 2025 was €63.5 Mil.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
WuXi XDC Cayman (FRA:L74) has a EV-to-FCF of 143.60 as of Sep. 01, 2026. EV to FCF ratio is the company's enterprise value divided by free cash flow. View historical data on WuXi XDC Cayman and its competitors. According to the industry distribution chart, WuXi XDC Cayman ranks #96 out of 104 companies in the Medical Diagnostics & Research industry, placing it in the top 92.3%.
Is WuXi XDC Cayman's EV-to-FCF too high?
WuXi XDC Cayman's current EV-to-FCF is 143.60. The Medical Diagnostics & Research industry median EV-to-FCF is 26.87. WuXi XDC Cayman's value of 143.60 is 434.4% above this industry median. Based on the distribution chart, WuXi XDC Cayman ranks #96 out of 104 companies in the Medical Diagnostics & Research industry, which is in the bottom quartile relative to peers. Overall, WuXi XDC Cayman has a GF Score™ of 55/100, reflecting its overall financial health beyond just this single metric.
How does WuXi XDC Cayman's EV-to-FCF compare to TMO and DHR?
According to the Medical Diagnostics & Research industry distribution chart, WuXi XDC Cayman ranks #96 out of 104 companies for EV-to-FCF. This places WuXi XDC Cayman in the lower half of its industry. The industry median EV-to-FCF is 26.87. WuXi XDC Cayman's value of 143.60 is 434.4% above this benchmark. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good EV-to-FCF for a Medical Diagnostics & Research company?
The median EV-to-FCF among Medical Diagnostics & Research companies is 26.87, based on 104 companies in the industry. Companies in the top quartile (top 25%) have a EV-to-FCF significantly above this median, while those in the bottom quartile fall well below. However, EV-to-FCF should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. WuXi XDC Cayman's current EV-to-FCF of 143.60 is 434.4% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high EV-to-FCF mean?
A high EV-to-FCF can signal that a stock is expensive relative to its fundamentals. EV to FCF ratio is the company's enterprise value divided by free cash flow. View historical data on WuXi XDC Cayman and its competitors. For the Medical Diagnostics & Research industry, the median EV-to-FCF is 26.87 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. WuXi XDC Cayman's current EV-to-FCF is 143.60. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is WuXi XDC Cayman stock overvalued right now?
WuXi XDC Cayman (FRA:L74) has a current EV-to-FCF of 143.60. The current EV-to-FCF is 143.60 and 434.4% above the Medical Diagnostics & Research industry median of 26.87. WuXi XDC Cayman's overall GF Score™ is 55/100 with 3 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is EV-to-FCF calculated?
EV-to-FCF is calculated from a company's financial statements. For WuXi XDC Cayman (FRA:L74), the current EV-to-FCF is 143.60 as of Sep. 01, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
WuXi XDC Cayman Inc is a CRDMO focused on the ADC and broader bioconjugate market and is the only one dedicated to providing integrated and end-to-end services. Leveraging expertise in both biologics and small molecules, it offers interdisciplinary and comprehensive services, covering bioconjugate discovery, research, development, and manufacturing. The company provides these services from proximately located laboratories and manufacturing facilities, resulting in the reduction of development timeline and costs. As a fully integrated one-stop bioconjugate discovery, development, and manufacturing platform, its mission is to continuously enhance its platform and propel and transform the development of the bioconjugate industry.
55GF Score
Get the complete analysis for FRA:L74
EV-to-FCF is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
FRA:L74 has been successfully added to your 
